Company Filing History:
1 out of 832,812 Years Active: 2009
Title: The Innovations of Xin Yong Yuan
Introduction
Xin Yong Yuan is an accomplished inventor based in Winnipeg, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies for combating the SARS-coronavirus. His work is crucial in the ongoing fight against viral infections and has implications for diagnostic tests and vaccine development.
Latest Patents
Xin Yong Yuan currently holds 1 patents. However, his notable work includes the development of anti-SARS monoclonal antibodies. These monoclonal antibody reagents are essential for recognizing the SARS-coronavirus, which has been a pressing need in the medical community.
Career Highlights
Xin Yong Yuan is associated with Her Majesty the Queen in Right of Canada, as represented by the Minister. His research focuses on the immunochemical characterization of monoclonal antibodies against SARS-HCoV. Initial screenings using ELISA led to the selection of seventeen monoclonal antibodies, with several demonstrating the ability to neutralize the virus in vitro.
Collaborations
Xin Yong Yuan has collaborated with notable colleagues, including Anton Andonov and Jody Berry. Their combined expertise enhances the research efforts in developing effective treatments against SARS and similar viral threats.
Conclusion
Xin Yong Yuan's contributions to the field of biotechnology, particularly in the development of anti-SARS monoclonal antibodies, highlight the importance of innovation in addressing global health challenges. His work continues to pave the way for advancements in diagnostic and therapeutic strategies.